During the last session, IGM Biosciences Inc (NASDAQ:IGMS)’s traded shares were 0.34 million, with the beta value of the company hitting 0.34. At the end
IGM Biosciences Inc (NASDAQ:IGMS)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting 0.34. At the close of
In last trading session, IGM Biosciences Inc (NASDAQ:IGMS) saw 0.31 million shares changing hands with its beta currently measuring -0.01. Company’s recent per share price
During the last session, IGM Biosciences Inc (NASDAQ:IGMS)’s traded shares were 0.57 million, with the beta value of the company hitting -0.04. At the end
In the last trading session, 0.32 million shares of the IGM Biosciences Inc (NASDAQ:IGMS) were traded, and its beta was 0.10. Most recently the company’s
IGM Biosciences Inc (NASDAQ:IGMS)’s traded shares stood at 2.79 million during the last session, with the company’s beta value hitting 0.17. At the close of
In the latest trading session, 0.69 million IGM Biosciences Inc (NASDAQ:IGMS) shares changed hands as the company’s beta touched 0.17. With the company’s most recent
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
